FDA Approved: NYSTATIN — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved Leading Pharma, LLC's Original Application (ANDA208838) to market a generic nystatin product (Nystatin). This represents the first generic approval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Mucocutaneous Candidiasis
• Oral Candidiasis

Drugs mentioned

• Nystatin (Nystatin)

Snippet

ORIG AP for NYSTATIN (NYSTATIN)